Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Sale | 2024-03-29 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.97 | $219,400 | 948,311 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.79 | $383,550 | 993,311 (Indirect Direct) | View |
| 2023-12-29 Sale | 2024-01-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $13.38 | $334,500 | 1,023,311 (Indirect Direct) | View |
| 2023-09-12 Purchase | 2023-12-18 6:30 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 640,000 | $10.74 | $6,871,279 | 4,383,875 (Indirect) | View |
| 2023-12-06 Purchase | 2023-12-08 4:19 pm | Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 100,000 | $11.6 | $1,160,000 | 7,903,600 (Indirect) | View |
| 2023-11-30 Sale | 2023-12-01 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.57 | $314,250 | 1,048,311 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 8,181 | $14.39 | $117,740 | 1,073,311 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,556 | $14.38 | $209,296 | 30,664 (Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 13,629 | $14.4 | $196,233 | 741,776 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 57,225 | $14.4 | $824,134 | 144,925 (Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 18,742 | $14.39 | $269,656 | 424,987 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 200 | $17.61 | $3,522 | 728,947 (Indirect Direct) | View |
| 2023-11-01 Sale | 2023-11-03 9:39 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 10,541 | $15.26 | $160,806 | 729,147 (Indirect Direct) | View |
| 2023-10-31 Sale | 2023-11-02 8:50 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.65 | $379,450 | 1,065,742 (Indirect Direct) | View |
| 2023-09-29 Sale | 2023-10-03 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,250 | 1,095,742 (Indirect Direct) | View |
| 2023-09-19 Sale | 2023-09-21 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 20,000 | $12.67 | $253,400 | 739,688 (Indirect Direct) | View |
| 2023-09-12 Purchase | 2023-09-14 4:25 pm | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 1,505,932 | $9.84 | $14,818,371 | 852,383 (Indirect Direct) | View |
| 2023-08-31 Sale | 2023-09-05 9:08 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $10.26 | $256,600 | 1,120,742 (Indirect Direct) | View |
| 2023-08-16 Sale(A) | 2023-09-05 4:05 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $10.14 | $152,100 | 1,023,714 (Direct) | View |
| 2023-08-16 Sale | 2023-08-17 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $10.14 | $152,100 | 1,145,742 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $0 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $4.87 | 216,664 (Direct) | View |
| 2024-03-05 Other | 2024-03-06 5:36 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 866,979 | $0 | 1,252,944 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 304,500 | $0 | 304,500 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 621,500 | $0 | 621,500 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $0 | 280,664 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 07:30 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 20,000 | $7.02 | 280,664 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-16 07:30 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 50,000 | $0 | 671,987 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-16 07:30 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 50,000 | $7.02 | 671,987 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 5:55 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 10,000 | $0 | 671,987 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-12 5:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 10,000 | $7.02 | 671,987 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:55 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 2,900 | $0 | 280,664 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 2,900 | $7.02 | 280,664 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 8:30 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,100 | $0 | 280,664 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 8:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,100 | $7.02 | 280,664 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,750 | $0 | 1,073,311 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 28,000 | $0 | 30,664 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 26,250 | $0 | 741,776 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 110,250 | $0 | 144,925 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 36,750 | $0 | 424,987 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 4:43 pm | N/A 2033-10-15 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 35,867 | $0 | 35,867 (Direct) | View |
Ownership | 2023-09-21 5:12 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 0 | $0 | 7,803,600 (Indirect) | View |
| 2023-09-14 Other | 2023-09-14 4:25 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 99,556 | $0 | 852,383 (Indirect) | View |
| 2023-06-16 Option Award | 2023-06-21 7:14 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 21,520 | $0 | 7,420,805 (Indirect) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director | 21,520 | $0 | 21,520 (Direct) | View |